Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus-Reference-Cited by-同舟云学术

Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus

Published:2016-11 Issue:11 Volume:18 Page:706-709
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Huang Ming-Hsi^ORCID,Dai Shih-Hsiung,Chong Pele

Funder

Ministry of Health and Welfare of Taiwan

NHRI

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference9 articles.

1. Pre-existing influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans;Wilkinson;Nat Med,2012

2. Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season;World Health Organization;WER,2016

3. Boosting our best shot;Schubert;Nat Med,2009

4. Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in Mice;Huang;PLoS One,2010

5. Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence;Chang;ACS Med Chem Lett,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphology and protein adsorption of aluminum phosphate and aluminum hydroxide and their potential catalytic function in the synthesis of polymeric emulsifiers;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2021-01

2. Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination;Journal for ImmunoTherapy of Cancer;2020-10

3. The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation;Vaccines;2020-05-27

4. Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine;Vaccines;2020-05-21

5. Noninvasive vaccination against infectious diseases;Human Vaccines & Immunotherapeutics;2018-05-17